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Dear Sir,
With great interest we read the article by Maass et al. [1]
who started a ‘quest for an atrium-specific biomarker’ using
oligodeoxyribonucleotide (ODN) microarrays to identify
differences in gene expression profile between atrial and
ventricular myocardium. One of the ‘atrium-enriched
genes’ is Nppa that has a ‘fold A/V microarray’ of 3.33
[1], whereas in hearts of healthy human adults, the
concentration of Nppa transcripts, which encode pre-
proANP (a precursor of atrial natriuretic peptide or ANP),
is >100-fold higher in atrial than in ventricular myocardium
[2, 3]. The explanation for this apparent discrepancy is that
gene expression profiling was done with RNA extracted
from neonatal rat atrial and ventricular cardiomyocytes.
This particular choice of tissue is highly peculiar, assuming
that the biomarker, once found, will be used in material
originating from adult human patients.
Foetal (and neonatal) rat (and human) atrial and
ventricular myocardium possess roughly equal proANP
concentrations [2, 3]. In adults, proANP is no longer found
in healthy rat and human ventricular myocardium [2, 3] but
reappears under pathological conditions such as heart
failure and hypertension [3, 4]. Furthermore, the heart of
newborns changes from a mainly glucose-metabolising
tissue to a primarily fatty acid-oxidising tissue, thereby
upregulating the expression of genes involved in fatty acid
transport and β-oxidation [5].
Another cautionary note concerns the tendency to equate
transcript/RNA levels as determined by ODN microarray
analysis with protein levels. This may not be justified
because: (1) Many genetic loci specify all kinds of non-
protein-coding transcripts besides the classical polyadeny-
lated protein-coding mRNAs that might contribute to the
signals observed on ‘DNA chips’ [6]; (2) Depending on the
stringency of the hybridisation and washing conditions, the
same DNA probe may be bound by related nucleic acid
sequences with different coding capacity; and (3) Cells
possess multiple mechanisms to control gene expression at
the post-transcriptional level [7], many of which affect the
ratio between a specific mRNA and the protein(s) it
encodes.
In conclusion, to find heart chamber type-specific
proteins that will potentially allow the identification of
atrium- or ventricle-specific biomarkers in human adults,
the use of adult human atrial and ventricular RNA for gene
expression profiling is recommended, provided any novel
candidate is tested at the protein level, e.g. by Western blot
analysis.
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